← Back to Conditions

Night blindness, skeletal anomalies, dysmorphism syndrome

disorder
SNOMED 1237228009CUI C5679607

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abnormal ERG
Very frequent (80-99%)HP:0000512
Abnormal palate morphology
Very frequent (80-99%)HP:0000174
Abnormality of retina blood vessels
Very frequent (80-99%)HP:0008046
Brachydactyly
Very frequent (80-99%)HP:0001156
Dental cavities
Very frequent (80-99%)HP:0000670
Difficulties with night vision
Very frequent (80-99%)HP:0000662
Eye drop
Very frequent (80-99%)HP:0000508
Hypotrophic malar bone
Very frequent (80-99%)HP:0000272
Joint ligamentous laxity
Very frequent (80-99%)HP:0001382
Near sighted
Very frequent (80-99%)HP:0000545
Palpebronasal fold
Very frequent (80-99%)HP:0000286
Retrognathia
Very frequent (80-99%)HP:0000278
Sloping shoulders
Very frequent (80-99%)HP:0200021
Unibrow
Very frequent (80-99%)HP:0000664
Abnormality of RPE
Frequent (30-79%)HP:0007703
Cognitive deficits
Frequent (30-79%)HP:0100543
Down-slanting palpebral fissure
Frequent (30-79%)HP:0000494
Heterochromia iridis
Frequent (30-79%)HP:0001100
Nasal anomaly
Frequent (30-79%)HP:0000366
Permanent curving of the pinkie finger
Frequent (30-79%)HP:0004209
Posteriorly angulated ears
Frequent (30-79%)HP:0000358
Scoliosis
Frequent (30-79%)HP:0002650
Spasticity and rigidity of muscles
Frequent (30-79%)HP:0001276

Quick Facts

SNOMED CT
1237228009
UMLS CUI
C5679607
Fully Specified Name
Night blindness, skeletal anomalies, dysmorphism syndrome (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
23
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.